4 results match your criteria: "Rotterdam Radiotherapeutic Institute[Affiliation]"
Caries Res
July 1989
Rotterdam Radiotherapeutic Institute, The Netherlands.
Postradiation caries is usually prevented by the application of topical fluorides (F) at high concentrations. The aim of this study was to develop an optimal preventive program for postradiation caries by evaluating the effects of F concentration and application procedures in subjects with radiation-related xerostomia. Six ground enamel slabs were mounted on each side of the lower denture of each of 7 xerostomia patients.
View Article and Find Full Text PDFInt J Hyperthermia
June 1988
Department of Hyperthermia, Rotterdam Radiotherapeutic Institute, The Netherlands.
Based upon a capacitive system a quasi-microwave cavity operating at a frequency of 13.56 or 27.12 MHz has been developed.
View Article and Find Full Text PDFCaries Res
March 1989
Rotterdam Radiotherapeutic Institute, The Netherlands.
The aim of this study was to develop an in vivo model in which onset, progression, and prevention of xerostomia-related dental caries can be studied. The progress of the caries process was investigated on ground and polished human enamel blocks placed in the lower denture of 7 edentulous subjects suffering from xerostomia. During a period of 6 weeks the samples were analyzed at weekly intervals by means of scanning optical monitoring, scanning longitudinal microradiography, scanning electron microscopy, and hardness measurements.
View Article and Find Full Text PDFFEMS Microbiol Immunol
January 1988
Department of Immunology, Dr. Daniel Den Hoed Cancer Center, Rotterdam Radiotherapeutic Institute, The Netherlands.
The biological response modifiers OK-432 and interleukin-2 (IL-2) were found to enhance the lytic capacity of cloned CD3- natural killer (NK) cells and CD3+ T cells. With respect to NK cells, only those clones with a high proliferative capacity and cultured without phytohaemagglutinin (PHA) responded with enhanced lytic capacity to OK-432. OK-432, but not IL-2, was found to augment the antibody-dependent cellular cytotoxicity of cloned NK cells.
View Article and Find Full Text PDF